Outcomes of COVID-19 in Ofatumumab-treated Patients with RMS: Data from the ALITHIOS Open-label Extension Study

Author:Boer, Ibolya   Cree, Bruce   Wiendl, Heinz   Cross, Anne   Delgado, Sylvia   Habek, Mario   Khachanova, Natalia   Ward, Brian   Totolyan, Natalia   Mancione, Linda   Sullivan, Roseanne   Zielman, Ronald   Hu, Xixi   Das Gupta, Ayan   Montalban, Xavier   Winthrop, Kevin   

Session Name:P1: Multiple Sclerosis: Clinical Practice and Decision Making 1  

Topic:Multiple Sclerosis  

Program Number:P1.010  

Author Institution:Novartis Pharma AG, Basel, Switzerland  UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA  Department of Neurology with Institute of Translational Neurology, University of Münster, Muenster, Germany  Washington University School of Medicine, Saint Louis, MO  University of Miami Miller School of Medicine, Miami, FL  University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia  Pirogov Russian National Research Medical University, Moscow, Russian Federation  Infectious Diseases Division, Research Institute of the McGill University Health Centre, Montreal, QC, Canada  First Saint Petersburg State Medical University, St Petersburg , Russian Federation  Novartis Pharmaceuticals Corporation, East Hanover, NJ  Novartis Pharma B.V, Amsterdam, Netherlands  Novartis Healthcare Private Limited, Hyderabad, India  Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain  School of Public Health at Oregon Health & Science University, Portland, OR  

Characteristics and Predictors Associated with 30-day Hospital Readmissions to Adult Neurology Services in a Large Academic Hospital

Performance of the 2023 Adult Criteria for the Radiologically Isolated Syndrome in Children and Comparison to the 2009 Criteria

Author:Makhani, Naila   Lebrun Frenay, Christine   Siva, Aksel   Shabanova, Veronika   Wassmer, Evangeline   Santoro, Jonathan   Narula, Sona   Brenton, James   Mar, Soe   Durand Dubief, Francoise   Zephir, Helene   Mathey, Guillaume   Rojas, Juan Ignacio   De Seze, Jerome   Tenembaum, Silvia   Thompson-Stone, Robert   Casez, Olivier   Carra-Dalliere, Clarisse   Neuteboom, Rinze F   Ahsan, Nusrat   Arroyo, Hugo   Cabre, Philippe   Gombolay, Grace   Inglese, Matilde   Louapre, Celine   Margoni, Monica   Palavra, Filipe   Pohl, Daniela   Reich, Daniel   Ruet, Aurelie   Thouvenot, Eric   Timby, Niklas   Tintore, Mar   Uygunoglu, Ugur   Vargas, Wendy   Verhelst, Helene   Wickstrom, Ronny   Azevedo, Christina   Kantarci, Orhun   Shapiro, Eugene   Okuda, Darin   Pelletier, Daniel   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.007  

Author Institution:Yale University School of Medicine, Department of Pediatrics, New Haven, CT  CRCSEP Neurologie, Nice, France  Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey  Birmingham Children's Hospital, Birmingham, United Kingdom  Department of Neurology, Children's Hospital Los Angeles, Los Angeles, CA  CHOP, Philadelphia, PA  University of Virginia, Charlottesville, VA  Washington University School of Medicine, Saint Louis, MO  Hopital Pierre Wertheimer, Bron Cedex, France  Hospital Roger Salengro, Lille Cedex, France  Nancy University Hospital, Ars Laquenexy, France  Hospital Italiano, Buenos Aires, Argentina  CHU de Strasbourg , Strasbourg, France  National Pediatric Hospital Dr. Juan P Garrahan, Buenos Aires, Argentina  University of Rochester, Rochester, NY  CHU De Grenoble, Grenoble, France  Montpellier University Hospital, Montpellier, France  Erasmus MC Rotterdam, Rotterdam, Netherlands  Hospital de Pediatría SAMIC. Prof. Dr. J.P. Garrahan, Buenos Aires, Argentina  CHU Martinique, Fort De France, Martinique  Emory University/Children'S Healthcare of Atlanta, Atlanta, GA  University of Genoa, Genoa, Italy  Hôpital Pitié Salpêtrière, APHP, Paris, France  27. Multiple Sclerosis Center of the Veneto Region, Milan, Italy  Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal  CHEO, Ottawa, ON, Canada  National Institutes of Health, Neuroimmunology Branch, NINDS, Bethesda, MD  Hopital Pellegrin, Bordeaux, France  CHU De Nimes - Hopital Caremeau, Nimes Cedex 9, France  Umea University, Umea, Sweden  34. MS Center of Catalunya Cemcat, Barcelona, Spain  none, New York, NY  University Hospital Ghent, Ghent, Belgium  Karolinska Institutet , Stockholm, Sweden  University of Southern California, Los Angeles, CA  Mayo Clinic, Rochester, MN  Yale Univ School of Medicine, New Haven, CT  UT Southwestern Medical Center, Dallas, TX  Keck School of Medicine of USC, Los Angeles, CA